<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04893733</url>
  </required_header>
  <id_info>
    <org_study_id>VBCNS</org_study_id>
    <nct_id>NCT04893733</nct_id>
  </id_info>
  <brief_title>Intravenous Administration of Vitamin B Complex Improves Renal Recovery in Patients With AKI</brief_title>
  <acronym>VIBAKI</acronym>
  <official_title>The Use of Intravenous Vitamin B Complex Improves Renal Recovery in Patients With Acute Kidney Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Caja Nacional de Salud</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>International Society of Nephrology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Caja Nacional de Salud</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Animal and human studies have shown that the administration of vitamin B3 (niacin) improves&#xD;
      renal ischemia; helping to recover from acute kidney injury (AKI) more effectively;&#xD;
      Therefore, its use in patients with AKI could improve short-term outcomes: accelerating the&#xD;
      recovery of renal function, reducing the days of hospital stay and costs; as well as reducing&#xD;
      the incidence of chronic kidney disease (CKD) or progression of CKD after an episode of AKI.&#xD;
&#xD;
      Our main objective is to determine the usefulness of the administration of vitamin B complex&#xD;
      as a treatment for established acute kidney injury and its effect on short and long-term&#xD;
      outcomes.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complete renal recovery</measure>
    <time_frame>Day 7</time_frame>
    <description>Serum creatinine (CrS) level returns to its baseline value or to a lower value.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Progression to Acute Kidney Disease (AKD)</measure>
    <time_frame>1 month</time_frame>
    <description>A eGFR &lt; than 60 ml/m/1.73m2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>De novo chronic kidney disease (CKD)</measure>
    <time_frame>3 months</time_frame>
    <description>An eGFR &lt; than 60 ml/m/1.73m2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Progression of CKD</measure>
    <time_frame>3 months</time_frame>
    <description>Patients progresses from a lower KDIGO CKD stage to a higher CKD stage</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Acute Kidney Injury</condition>
  <arm_group>
    <arm_group_label>Vitamin B complex</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Randomized patients with AKI to this arm will received during 5 consecutive days IV Vitamin B complex each 12 hours. They will also received the Institution standard of care for AKI.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Randomized patients with AKI to this arm will received during 5 consecutive days IV placebo each 12 hours. They will also received the Institution standard of care for AKI.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin B Complex</intervention_name>
    <description>Patients with established AKI will be randomized to received IV vitamin B complex each 1 hours for 5 consecutive days versus placebo.&#xD;
Every patients will also received Institution standard of care for AKI</description>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>Vitamin B complex</arm_group_label>
    <other_name>Placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients over 18 years of age who meet modified KDIGO criteria for Acute Kidney&#xD;
             Injury, based on serum creatinine or urinary volume criteria.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient under 18 years of age&#xD;
&#xD;
          -  Patients with stage G5 chronic kidney disease&#xD;
&#xD;
          -  Patients with chronic kidney replacement therapy.&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Transplant patients&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rolando Claure-Del Granado, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Obrero No 2 - C.N.S.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rolando Claure-Del Granado, M.D.</last_name>
    <phone>+591 75908833</phone>
    <email>rclaure@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Obrero No 2 - C.N.S.</name>
      <address>
        <city>Cochabamba</city>
        <zip>0</zip>
        <country>Bolivia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rolando Claure-Del Granado, M.D.</last_name>
      <phone>+591 75908833</phone>
      <email>rclaure@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Ariana Torrico, M.D.</last_name>
      <phone>+591 61677773</phone>
      <email>ari-torrico13@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Ariana Torrico, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Bolivia</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 16, 2021</study_first_submitted>
  <study_first_submitted_qc>May 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 19, 2021</study_first_posted>
  <last_update_submitted>May 16, 2021</last_update_submitted>
  <last_update_submitted_qc>May 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Caja Nacional de Salud</investigator_affiliation>
    <investigator_full_name>Rolando Claure-Del Granado</investigator_full_name>
    <investigator_title>Head Division of Nephrology</investigator_title>
  </responsible_party>
  <keyword>Acute Kidney Injury</keyword>
  <keyword>Vitamin B complex</keyword>
  <keyword>Creatinine</keyword>
  <keyword>Proteinuria</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Folic Acid</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

